Literature DB >> 21288196

High-throughput methods in identification of protein tyrosine phosphatase inhibitors and activators.

Elina Mattila1, Johanna Ivaska.   

Abstract

Reversible protein tyrosine phosphorylation, catalysed by the counter-actors protein tyrosine phosphatases (PTPs) and protein tyrosine kinases (PTKs), is a fundamentally important regulatory mechanism of proteins in living cells, controlling cell communication, proliferation, differentiation, motility, and molecular trafficking. The activities of PTPs and PTKs are derailed in several diseases such as cancer and type II diabetes, making them attractive drug targets. Developing drugs against PTKs has started a decade earlier than that on PTPs, and at present there are several molecules targeting PTKs on the market. PTPs in turn are of raising interest, with PTP1B on the lead for its effects on type II diabetes and obesity. In the search for modulators of PTP activity, high-throughput methods are important as the initial step to find suitable lead compounds for drug development. Also, high-throughput methods are very useful in elucidating the specific function of different PTPs. In this review, the different high-throughput studies performed to find inhibitors and activators of classical PTPs are discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21288196     DOI: 10.2174/187152011794941235

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  7 in total

1.  Allosteric inhibitors of the Eya2 phosphatase are selective and inhibit Eya2-mediated cell migration.

Authors:  Aaron B Krueger; David J Drasin; Wendy A Lea; Aaron N Patrick; Samarjit Patnaik; Donald S Backos; Christopher J Matheson; Xin Hu; Elena Barnaeva; Michael J Holliday; Melanie A Blevins; Tyler P Robin; Elan Z Eisenmesser; Marc Ferrer; Anton Simeonov; Noel Southall; Philip Reigan; Juan Marugan; Heide L Ford; Rui Zhao
Journal:  J Biol Chem       Date:  2014-04-22       Impact factor: 5.157

2.  Activation of Engineered Protein Tyrosine Phosphatases with the Biarsenical Compound AsCy3-EDT2.

Authors:  Wai Cheung Chan; Gregory S Knowlton; Anthony C Bishop
Journal:  Chembiochem       Date:  2017-08-23       Impact factor: 3.164

3.  Integrating virtual and biochemical screening for protein tyrosine phosphatase inhibitor discovery.

Authors:  Katie R Martin; Pooja Narang; José L Medina-Franco; Nathalie Meurice; Jeffrey P MacKeigan
Journal:  Methods       Date:  2013-08-20       Impact factor: 3.608

4.  Virtual and experimental high-throughput screening (HTS) in search of novel inosine 5'-monophosphate dehydrogenase II (IMPDH II) inhibitors.

Authors:  Torsten Dunkern; Arati Prabhu; Prashant S Kharkar; Heike Goebel; Edith Rolser; Waltraud Burckhard-Boer; Premkumar Arumugam; Mahindra T Makhija
Journal:  J Comput Aided Mol Des       Date:  2012-11-02       Impact factor: 3.686

5.  Chemical activation of divergent protein tyrosine phosphatase domains with cyanine-based biarsenicals.

Authors:  Bailey A Plaman; Wai Cheung Chan; Anthony C Bishop
Journal:  Sci Rep       Date:  2019-11-06       Impact factor: 4.379

6.  Label-Free Fluorescent Kinase and Phosphatase Enzyme Assays with Supramolecular Host-Dye Pairs.

Authors:  Yan-Cen Liu; Shu Peng; Lora Angelova; Werner M Nau; Andreas Hennig
Journal:  ChemistryOpen       Date:  2019-11-12       Impact factor: 2.911

7.  Identification of small molecule inhibitors of PTPσ through an integrative virtual and biochemical approach.

Authors:  Katie R Martin; Pooja Narang; Yong Xu; Audra L Kauffman; Joachim Petit; H Eric Xu; Nathalie Meurice; Jeffrey P MacKeigan
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.